As the NHS shifts from treatment to prevention, why is screening so critical?

Preventative care is rapidly becoming one of the most important pillars of modern healthcare.

The UK Government’s proposed 10-year shift from treatment to prevention aims to rebalance the health system so that the National Health Service focuses more on early intervention, screening and lifestyle support, shifting attention from treating illness after it develops to earlier detection, risk assessment and proactive monitoring.

With healthcare providers in the UK facing growing pressure from long waiting lists, and more than 900,000 cancer diagnoses detected through screening in the past five years alone, the value of early detection is increasingly recognised.

Here, Dr Stephen Feldman, Founder and Director of Yorkshire-based LivingCare Group, who has more than 40 years’ experience in health and diagnostic care, discusses why earlier detection, proactive monitoring and timely access to testing are key to improving outcomes.

Treatment vs prevention

This 10-year reform plan is driving a shift away from treating illness after it occurs and towards preventing disease in the first place.

By prioritising earlier detection, vaccination, lifestyle interventions and community-based care, the aim is to keep people healthier for longer while easing long-term pressure on health services.

With sustained pressures on the health service, more people are taking proactive steps to monitor their health. This includes the use of wearable devices, regular health checks, blood tests and proactive screening, particularly where there are risk factors or a family history of illness.

It is also increasingly common for employers to provide health checks as an employee benefit alongside traditional private medical insurance and cash plans.

This shift towards preventative care is particularly significant in prostate cancer, where early intervention can dramatically alter outcomes.